Urokinase plasminogen activator and cathepsin D in micrometastatic cells of patients with primary breast cancer

被引：0
|
作者：
Solomayer, EF [1 ]
Diel, IJ [1 ]
Gollan, C [1 ]
Meyberg, G [1 ]
Bode, S [1 ]
Wallwiener, D [1 ]
Bastert, G [1 ]
机构：
[1] Univ Heidelberg, Dept OB GYN, D-69115 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89259-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P41
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] The urokinase plasminogen activator system in breast cancer invasion and metastasis
    Tang, Linlin
    Han, Xiuzhen
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (02) : 179 - 182
  • [22] Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer
    Duffy, MJ
    Duggan, C
    Maguire, T
    Mulcahy, K
    Elvin, P
    McDermott, E
    Fennelly, JJ
    OHiggins, N
    ENZYME & PROTEIN, 1996, 49 (1-3) : 85 - 93
  • [23] Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
    Tögel, F
    Datta, C
    Badbaran, A
    Kröger, N
    Renges, H
    Gieseking, F
    Jänicke, F
    Zander, AR
    Krüger, W
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (01): : 141 - 145
  • [24] UROKINASE PLASMINOGEN-ACTIVATOR AND PROGNOSIS IN BREAST-CANCER
    DUFFY, MJ
    REILLY, D
    OSULLIVAN, C
    OHIGGINS, N
    FENNELLY, JJ
    LANCET, 1990, 335 (8681): : 108 - 108
  • [25] Clinical relevance of the urokinase plasminogen activator system in breast cancer
    Look, MP
    Foekens, JA
    APMIS, 1999, 107 (01) : 150 - 159
  • [26] Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer
    GrondahlHansen, J
    Peters, HA
    vanPutten, WLJ
    Look, MP
    Pappot, H
    Ronne, E
    Dano, K
    Klijn, JGM
    Brunner, N
    Foekens, JA
    CLINICAL CANCER RESEARCH, 1995, 1 (10) : 1079 - 1087
  • [27] Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells
    Zhang, Shuqun
    Ma, Yinan
    Jiang, Jiantao
    Dai, Zhijun
    Gao, Xiaoyan
    Yin, Xiaoran
    Xi, Wentao
    Min, Weili
    ONCOLOGY LETTERS, 2014, 7 (05) : 1375 - 1380
  • [28] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 I IN BREAST-CANCER CELLS
    WAJIMA, T
    DEGEN, D
    ORIZ, V
    VONHOFFOLIN, DD
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1284 - 1284
  • [29] Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients
    Pierga, JY
    Bonneton, C
    Magdelénat, H
    Vincent-Salomon, A
    Nos, C
    Boudou, E
    Pouillart, P
    Thiery, JP
    de Cremoux, P
    INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (02) : 291 - 298
  • [30] Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
    Nielsen, BS
    Sehested, M
    Timshel, S
    Pyke, C
    Dano, K
    LABORATORY INVESTIGATION, 1996, 74 (01) : 168 - 177
12345